Anti-Alzheimer's drug lecanemab

Anti-Alzheimer's drug lecanemab

Haruo Naito, CEO of Japanese pharmaceutical company Eisai Co., attends a press conference in Tokyo on Dec. 13, 2023, as the company's anti-Alzheimer's drug lecanemab is set to be launched on Dec. 20, following a health ministry advisory body's approval of its coverage by the Japanese public insurance scheme.

  • Product Code
  • ILEA002090398
  • Registered date
  • 2023/12/13 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2023 Kyodo News
  • Media size
  • 3918 × 2806 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 532.56(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos